Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 14/20 | 0.66 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.45 |
| ▸ | TOP2A | P11388 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2768409 | 1.00 | KCNH2 (0.66) | KCNH2SLC2A1TOP2A | |
| SCHEMBL2768016 | 1.00 | KCNH2 (0.66) | KCNH2SLC2A1TOP2A | |
| SCHEMBL2767951 | 0.94 | KCNH2 (0.68) | KCNH2SLC2A1TOP2A | |
| SCHEMBL2767542 | 0.94 | KCNH2 (0.68) | KCNH2SLC2A1TOP2A | |
| SCHEMBL13244867 | 0.91 | KCNH2 (0.56) | KCNH2SLC2A1TOP2A | |
| SCHEMBL3469114 | 0.91 | KCNH2 (0.56) | KCNH2SLC2A1TOP2A | |
| SCHEMBL2768460 | 0.91 | KCNH2 (0.54) | KCNH2SLC2A1 | |
| SCHEMBL3478626 | 0.91 | KCNH2 (0.54) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL2768275 | 0.90 | KCNH2 (0.53) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL2770784 | 0.90 | KCNH2 (0.53) | KCNH2SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167196-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | Glaxo Group Limited (GB) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009000745-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | GLAXO GROUP LIMITED (GB) | 2008-12-31 | — | — | WO | disclosed |